OncoImmunology (Dec 2022)

Oncolytic adenovirus promotes vascular normalization and nonclassical tertiary lymphoid structure formation through STING-mediated DC activation

  • Teng He,
  • Zhixing Hao,
  • Mingjie Lin,
  • Zhongwei Xin,
  • Yongyuan Chen,
  • Wei Ouyang,
  • Qi Yang,
  • Xiaoke Chen,
  • Hui Zhou,
  • Wanying Zhang,
  • Pin Wu,
  • Feng Xu

DOI
https://doi.org/10.1080/2162402X.2022.2093054
Journal volume & issue
Vol. 11, no. 1

Abstract

Read online

Inducing a full antitumor immune response in the tumor microenvironment (TME) is essential for successful cancer immunotherapy. Here, we report that an oncolytic adenovirus carrying mIL-15 (Ad-IL15) can effectively induce antitumor immune response and inhibit tumor growth in a mouse model of cancer. We found that Ad-IL15 facilitated the activation and infiltration of immune cells, including dendritic cells (DCs), T cells and natural killer (NK) cells, in the TME. Unexpectedly, we observed that Ad-IL15 also induced vascular normalization and tertiary lymphoid structure formation in the TME. Moreover, we demonstrated these Ad-IL15-induced changes in the TME were depended on the Ad-IL15-induced activation of the STING-TBK1-IRF3 pathway in DCs. Taken together, our findings suggest that Ad-IL15 is a candidate for cancer immunotherapy that promotes immune cell activation and infiltration, tumor vascular normalization and tertiary lymphoid structure formation in the TME.

Keywords